These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 33509178)

  • 21. A Global and Integrated Analysis of CINSARC-Associated Genetic Defects.
    Lesluyes T; Chibon F
    Cancer Res; 2020 Dec; 80(23):5282-5290. PubMed ID: 33023949
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multi-omics analysis of tumor angiogenesis characteristics and potential epigenetic regulation mechanisms in renal clear cell carcinoma.
    Zheng W; Zhang S; Guo H; Chen X; Huang Z; Jiang S; Li M
    Cell Commun Signal; 2021 Mar; 19(1):39. PubMed ID: 33761933
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In silico DNA methylation analysis identifies potential prognostic biomarkers in type 2 papillary renal cell carcinoma.
    Yang M; Hlady RA; Zhou D; Ho TH; Robertson KD
    Cancer Med; 2019 Sep; 8(12):5760-5768. PubMed ID: 31361072
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of seven-gene marker to predict the survival of patients with lung adenocarcinoma using integrated multi-omics data analysis.
    Zhang S; Zeng X; Lin S; Liang M; Huang H
    J Clin Lab Anal; 2022 Feb; 36(2):e24190. PubMed ID: 34951053
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subtype-specific signaling pathways and genomic aberrations associated with prognosis of glioblastoma.
    Park AK; Kim P; Ballester LY; Esquenazi Y; Zhao Z
    Neuro Oncol; 2019 Jan; 21(1):59-70. PubMed ID: 30053126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of tumor suppressors and oncogenes from genomic and epigenetic features in ovarian cancer.
    Wrzeszczynski KO; Varadan V; Byrnes J; Lum E; Kamalakaran S; Levine DA; Dimitrova N; Zhang MQ; Lucito R
    PLoS One; 2011; 6(12):e28503. PubMed ID: 22174824
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Can DNA Methylation Profiling Classify Histologic Subtypes and Grades in Soft Tissue Sarcoma?
    Kim H; Joo MW; Yoon J; Park HS; Kim JH; Lee JH; Kim SH; Lee SK; Chung YG; Cho YJ
    Clin Orthop Relat Res; 2024 Mar; 482(6):1028-37. PubMed ID: 38517415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In silico recognition of a prognostic signature in basal-like breast cancer patients.
    Conte F; Sibilio P; Grimaldi AM; Salvatore M; Paci P; Incoronato M
    PLoS One; 2022; 17(2):e0264024. PubMed ID: 35167614
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exploring biomarkers for prognosis and neoadjuvant chemosensitivity in rectal cancer: Multi-omics and ctDNA sequencing collaboration.
    Jiang XF; Zhang BM; Du FQ; Guo JN; Wang D; Li YE; Deng SH; Cui BB; Liu YL
    Front Immunol; 2022; 13():1013828. PubMed ID: 36569844
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of Potential Biomarkers From Hepatocellular Carcinoma With MT1 Deletion.
    Zhang R; Huang M; Wang H; Wu S; Yao J; Ge Y; Lu Y; Hu Q
    Pathol Oncol Res; 2021; 27():597527. PubMed ID: 34257549
    [No Abstract]   [Full Text] [Related]  

  • 31. Cuproptosis-Related Signature Predicts the Prognosis, Tumor Microenvironment, and Drug Sensitivity of Hepatocellular Carcinoma.
    Qi X; Guo J; Chen G; Fang C; Hu L; Li J; Zhang C
    J Immunol Res; 2022; 2022():3393027. PubMed ID: 36438201
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development and validation of an immune gene-set based prognostic signature for soft tissue sarcoma.
    Shen R; Liu B; Li X; Yu T; Xu K; Ma J
    BMC Cancer; 2021 Feb; 21(1):144. PubMed ID: 33557781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
    Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J
    Front Immunol; 2021; 12():669750. PubMed ID: 34054840
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identifying enhancer-driven subtype-specific prognostic markers in breast cancer based on multi-omics data.
    Zhao H; Zhang S; Yin X; Zhang C; Wang L; Liu K; Xu H; Liu W; Bo L; Lin S; Feng K; Lin L; Fei M; Ning S; Wang L
    Front Immunol; 2022; 13():990143. PubMed ID: 36304471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Walking pathways with positive feedback loops reveal DNA methylation biomarkers of colorectal cancer.
    Kel A; Boyarskikh U; Stegmaier P; Leskov LS; Sokolov AV; Yevshin I; Mandrik N; Stelmashenko D; Koschmann J; Kel-Margoulis O; Krull M; Martínez-Cardús A; Moran S; Esteller M; Kolpakov F; Filipenko M; Wingender E
    BMC Bioinformatics; 2019 Apr; 20(Suppl 4):119. PubMed ID: 30999858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Survival differences of CIMP subtypes integrated with CNA information in human breast cancer.
    Wang H; Yan W; Zhang S; Gu Y; Wang Y; Wei Y; Liu H; Wang F; Wu Q; Zhang Y
    Oncotarget; 2017 Jul; 8(30):48807-48819. PubMed ID: 28415743
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genome wide methylation profiling of selected matched soft tissue sarcomas identifies methylation changes in metastatic and recurrent disease.
    Vargas AC; Gray LA; White CL; Maclean FM; Grimison P; Ardakani NM; Bonar F; Algar EM; Cheah AL; Russell P; Mahar A; Gill AJ
    Sci Rep; 2021 Jan; 11(1):667. PubMed ID: 33436720
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Machine learning and multi-omics data reveal driver gene-based molecular subtypes in hepatocellular carcinoma for precision treatment.
    Wang M; Yan X; Dong Y; Li X; Gao B
    PLoS Comput Biol; 2024 May; 20(5):e1012113. PubMed ID: 38728362
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of novel prognostic biomarkers by integrating multi-omics data in gastric cancer.
    Liu N; Wu Y; Cheng W; Wu Y; Wang L; Zhuang L
    BMC Cancer; 2021 Apr; 21(1):460. PubMed ID: 33902514
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Integrated analysis of methylation and transcriptome identifies a novel risk model for diagnosis, prognosis, and immune characteristics in head and neck squamous cell carcinoma.
    Zhang JW; Gao XL; Li S; Zhuang SH; Liang QW
    Mol Genet Genomics; 2024 Jul; 299(1):71. PubMed ID: 39031208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.